Field comparison of the point velocity probe with other groundwater velocity measurement methods

Field testing of a new tool for measuring groundwater velocities at the centimeter scale, the point velocity probe (PVP), was undertaken at Canadian Forces Base, Borden, Ontario, Canada. The measurements were performed in a sheet pile-bounded alleyway in which bulk flow rate and direction could be controlled. PVP velocities were compared with those estimated from bulk flow, a Geoflo® instrument, borehole dilution, colloidal borescope measurements, and a forced gradient tracer test. In addition, the velocity profiles were compared with vertical variations in hydraulic conductivity (K) measured by permeameter testing of core samples and in situ high-resolution slug tests. There was qualitative agreement between the trends in velocity and K among all the various methods. The PVP and Geoflo® meter tests returned average velocity magnitudes of 30.2 ± 7.7 to 34.7 ± 13.1 cm/d (depending on prior knowledge of flow direction in PVP tests) and 36.5 ± 10.6, respectively, which were near the estimated bulk velocity (20 cm/d). The other direct velocity measurement techniques yielded velocity estimates 5 to 12 times the bulk velocity. Best results with the PVP instrument were obtained by jetting the instrument into place, though this method may have introduced a slight positive bias to the measured velocities. The individual estimates of point velocity direction varied, but the average of the point velocity directions agreed quite well with the expected bulk flow direction. It was concluded that the PVP method is a viable technique for use in the field, where high-resolution velocity data are required.The NSERC/Motorola/ETI Industrial Research Chair in Groundwater Remediation, NSERC, CRESTech, the National Council for Scientific Research of Lebanon (NCSR), OGSST, and NSF under grant 0134545 are acknowledged for funding this work. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. Carl McElwee performed the high-definition slug tests; Peter Kearl performed the colloidal borescope measurements; and Bob Ingleton, Paul Johnson, and Greg Friday assisted with probe construction and field installatio

Paper Session II-A - The Testability of Software for the Space Station Freedom Program

The Space Station Freedom Data Management System consists of state-of-the-art hardware and software technology that exceeds the capabilities of earlier test tools and methods used to verify and certify man-rated space systems. New technologies and techniques are being developed to meet these challenges

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

Nivolumab; Carcinoma cervical, vaginal o vulvar; Carcinoma metastàticNivolumab; Cervical, vaginal, or vulvar carcinoma; Metastatic carcinomaNivolumab; Carcinoma de cuello uterino, vaginal o vulvar; Carcinoma metastáticoPURPOSE Nivolumab was assessed in patients with virus-associated tumors in the phase I/II CheckMate 358 trial (ClinicalTrials.gov identifier: NCT02488759). We report on patients with recurrent/metastatic cervical, vaginal, or vulvar cancers. PATIENTS AND METHODS Patients received nivolumab 240 mg every 2 weeks. Although patients with unknown human papillomavirus status were enrolled, patients known to have human papillomavirus–negative tumors were ineligible. The primary end point was objective response rate. Duration of response (DOR), progression-free survival, and overall survival were secondary end points. Safety and patient-reported outcomes were exploratory end points. RESULTS Twenty-four patients (cervical, n = 19; vaginal/vulvar, n = 5) were enrolled. Most patients had received prior systemic therapy for metastatic disease (cervical, 78.9%; vaginal/vulvar, 80.0%). Objective response rates were 26.3% (95% CI, 9.1 to 51.2) for cervical cancer and 20.0% (95% CI, 0.5 to 71.6) for vaginal/vulvar cancers. At a median follow-up of 19.2 months, median DOR was not reached (range, 23.3 to 29.5+ months; + indicates a censored observation) in the five responding patients in the cervical cohort; the DOR was 5.0 months in the single responding patient in the vaginal/vulvar cohort. Median overall survival was 21.9 months (95% CI, 15.1 months to not reached) among patients with cervical cancer. Any-grade treatment-related adverse events were reported in 12 of 19 patients (63.2%) in the cervical cohort and all five patients in the vaginal/vulvar cohort; there were no treatment-related deaths. In the cervical cohort, nivolumab treatment generally resulted in stabilization of patient-reported outcomes associated with health status and health-related quality of life. CONCLUSION The efficacy of nivolumab in patients with recurrent/metastatic cervical and vaginal or vulvar cancers is promising and warrants additional investigation. No new safety signals were identified with nivolumab treatment in this population

Developing Historic Building Information Modelling Guidelines and Procedures for Architectural Heritage in Ireland

Cultural heritage researchers have recently begun applying Building Information Modelling (BIM) to historic buildings. The model is comprised of intelligent objects with semantic attributes which represent the elements of a building structure and are organised within a 3D virtual environment. Case studies in Ireland are used to test and develop the suitable systems for (a) data capture/digital surveying/processing (b) developing library of architectural components and (c) mapping these architectural components onto the laser scan or digital survey to relate the intelligent virtual representation of a historic structure (HBIM). While BIM platforms have the potential to create a virtual and intelligent representation of a building, its full exploitation and use is restricted to narrow set of expert users with access to costly hardware, software and skills. The testing of open BIM approaches in particular IFCs and the use of game engine platforms is a fundamental component for developing much wider dissemination. The semantically enriched model can be transferred into a WEB based game engine platform

Herschel and ALMA observations of the ISM in massive high-redshift galaxy clusters

The Sunyaev-Zel'dovich effect (SZE) can be used to select samples of galaxy clusters that are essentially mass-limited out to arbitrarily high redshifts. I will present results from an investigation of the star formation properties of galaxies in four massive clusters, extending to z~1, which were selected on the basis of their SZE decrements in the Atacama Cosmology Telescope (ACT) survey. All four clusters have been imaged with Herschel/PACS (tracing star formation rate) and two with ALMA (tracing dust and cold gas mass); newly discovered ALMA CO(4-3) and [CI] line detections expand an already large sample of spectroscopically confirmed cluster members. Star formation rate appears to anti-correlate with environmental density, but this trend vanishes after controlling for stellar mass. Elevated star formation and higher CO excitation are seen in "El Gordo," a violent cluster merger, relative to a virialized cluster at a similar high (z~1) redshift. Also exploiting ATCA 2.1 GHz observations to identify radio-loud active galactic nuclei (AGN) in our sample, I will use these data to develop a coherent picture of how environment influences galaxies' ISM properties and evolution in the most massive clusters at early cosmic times